Herd immunity: only one in ten Brits had Covid-19 antibodies by December
New ONS data shows that majority of population are still at risk of infection
The number of people in the UK testing positive for Covid-19 antibodies is not rising quickly enough for natural herd immunity to develop, new data from the Office for National Statistics suggests.
An estimated one in ten people had immunity against the coronavirus in December, according to latest infection survey figures.
In October, antibody positivity - which indicates past infection with the virus - ranged from 2% to 7% across Britain. By last month, those totals had risen to 12% in England, 10% in Wales, 9% in Scotland and 8% in Northern Ireland
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
But in a blow to advocates of herd immunity, experts say that antibodies are still a long way from being widespread enough to lower infection rates.
A study published by John Hopkins University last year found that to reach herd immunity for Covid-19, around 70% or more of the population would need to have antibodies.
“In addition, while having antibodies can offer protection against reinfection, it is not yet known what levels are needed to reduce the chance of getting Covid again,” says The Guardian.
And antibody levels decline over time, so infection may not provide long-term protection.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Professor Danny Altmann, an immunologist at Imperial College London who was not involved in the ONS survey, told the newspaper that “this is a dynamic picture - many who were infected during the March-April peak may no longer appear positive”.
Echoing warnings from other specialists, Altmann said that the number of people in the UK with antibodies was “not rising quickly, meaning natural herd immunity had not developed and that vaccines remained crucial to tackling the disease”, The Guardian adds.
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
Will Biden's AI rules keep the genie in the bottle?
Talking Points A new blow in the race for 'geopolitical superiority'
By Joel Mathis, The Week US Published
-
Israel and Hamas reach long awaited Gaza ceasefire
The Explainer After more than a year of violence that has left tens of thousands dead and pushed the Middle East toward broader regional war, negotiators say an end is in sight
By Rafi Schwartz, The Week US Published
-
Hang 10 at El Zonte, a surfer's paradise in El Salvador
The Week Recommends Catch some waves and a great cup of coffee
By Catherine Garcia, The Week US Published
-
The UK's first legal drug consumption room
The Explainer 'Potentially transformative moment in UK drugs policy' as The Thistle opens in Glasgow
By The Week UK Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
How can the UK solve the adult social care crisis?
Today's Big Question New commission announced to turn our buckling care sector around: yet more delay or finally a way forward?
By Elizabeth Carr-Ellis, The Week UK Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Should blood donors be paid?
The Explainer Financial rewards would help fill NHS shortfall but bring risk of contamination and exploitation, WHO warns
By The Week UK Published
-
UK gynaecological care crisis: why thousands of women are left in pain
The Explainer Waiting times have tripled over the past decade thanks to lack of prioritisation or funding for women's health
By Harriet Marsden, The Week UK Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published